| RS1064792948 |
RAD50
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1064792950 |
UBE3A
|
Health Risk |
Pathogenic |
Angelman syndrome, Angelman syndrome |
| RS1064792951 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1064792957 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1064792958 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1064792959 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS1064792960 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1064792961 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1064792962 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1064792966 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS1064792967 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1064792968 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1064792970 |
CASR
|
Health Risk |
Pathogenic |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS1064792974 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Hereditary retinoblastoma |
| RS1064792977 |
APC
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1064792978 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1064792979 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1064792980 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1064792983 |
TMEM67
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1064792984 |
SYNGAP1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS1064792985 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS1064792986 |
REEP1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 31, Hereditary spastic paraplegia 31 |
| RS1064792988 |
BAP1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1064792996 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Tuberous sclerosis syndrome |
| RS1064792998 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS1064792999 |
ZBTB18
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 22 |
| RS1064793000 |
ARHGEF18
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 78, Retinitis pigmentosa 78 |
| RS1064793001 |
ARHGEF18
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 78, Retinitis pigmentosa 78 |
| RS1064793002 |
ARHGEF18
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 78, Retinitis pigmentosa 78 |
| RS1064793003 |
SMAD6
|
Health Risk |
Conflicting classifications of pathogenicity |
CRANIOSYNOSTOSIS 7, SUSCEPTIBILITY TO |
| RS1064793004 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1064793005 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1064793006 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1064793007 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS1064793008 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS1064793009 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1064793010 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1064793011 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, ABCA4-related disorder |
| RS1064793012 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS1064793013 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1064793014 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS1064793015 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS1064793020 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial multiple polyposis syndrome |
| RS1064793021 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1064793022 |
APC
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1064793023 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1064793024 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1064793026 |
ARSB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1064793027 |
ARSB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1064793029 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1064793031 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1064793033 |
ATM
|
Health Risk |
Pathogenic |
— |
| RS1064793042 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS1064793043 |
ATM
|
Health Risk |
Pathogenic |
ATM-related disorder, ATM-related disorder |
| RS1064793046 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1064793049 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Malignant tumor of breast |
| RS1064793050 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1064793051 |
BEST1
|
Health Risk |
Likely pathogenic |
— |
| RS1064793052 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS1064793054 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1064793055 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1064793056 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1064793057 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1064793059 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1064793061 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1064793062 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1064793063 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1064793064 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1064793065 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1064793066 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1064793067 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1064793068 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1064793069 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1064793073 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1064793074 |
MTRFR
|
Health Risk |
Likely pathogenic |
— |
| RS1064793075 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1064793076 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, childhood absence |
| RS1064793078 |
CALM1
|
Health Risk |
Likely pathogenic |
— |
| RS1064793081 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Melanoma-pancreatic cancer syndrome, Melanoma-pancreatic cancer syndrome |
| RS1064793083 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS1064793084 |
CHD7
|
Health Risk |
Likely pathogenic |
— |
| RS1064793090 |
CREBBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Rubinstein-Taybi syndrome |
| RS1064793092 |
CUL7
|
Health Risk |
Likely pathogenic |
— |
| RS1064793093 |
CYBB
|
Health Risk |
Conflicting classifications of pathogenicity |
Granulomatous disease, chronic |
| RS1064793097 |
DARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome, Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome |
| RS1064793101 |
DNM2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease dominant intermediate B, Charcot-Marie-Tooth disease dominant intermediate B |
| RS1064793103 |
DSG2
|
Health Risk |
Likely pathogenic |
— |
| RS1064793104 |
EDA
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Tooth agenesis |
| RS1064793105 |
EDA
|
Health Risk |
Likely pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS1064793106 |
EDA
|
Health Risk |
Likely pathogenic |
Thyroid cancer, nonmedullary |
| RS1064793107 |
EDAR
|
Health Risk |
Likely pathogenic |
— |
| RS1064793108 |
ELANE
|
Health Risk |
Pathogenic/Likely pathogenic |
Neutropenia, severe congenital |
| RS1064793109 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
FANCC-related disorder, Hereditary cancer-predisposing syndrome |
| RS1064793110 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group C, Hereditary cancer-predisposing syndrome |
| RS1064793112 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1064793113 |
FBN1
|
Health Risk |
Likely pathogenic |
— |
| RS1064793114 |
FBN1
|
Health Risk |
Likely pathogenic |
— |
| RS1064793115 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS1064793116 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1064793117 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |